Randamized clinical trial of reduction in the recurrence of acute noncardioembolic stroke by Cilostazol and Eicosapentaneic acid for hypercholesterolemic patients - Cilostazol and EPA stroke prevention study (CESP study)

Department of Neurology, Tokyo Medical University0 个研究点目标入组 500 人开始时间: 2014年5月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Patients with a history of acute myocardial infarction within six months Patients with congestive heart failure or uncontrolled angina pectoris Patients with a history of caridiovascular angioplasty within six months Patients with severe liver or renal dysfunction Patients with a malignant tumor requiring treatment Patients with uncontrolled diabetes mellitus Patients with secondary dyslipidemia (due to corticosteroid etc) Patients with hemorrhagic diseases (eg. Hemophilia, hemorrhagic intestinal diseases, hemorrhage from gastrointesitinal tract and urinary tract, hemoptysis) Patients with hypersensitivity to aspirin, clopidogrel or cilostazol Patients scheduled to undergo any surgery during the study period Patients considered by the investigator/subinvestigator to be unsuitable for participating in this study

发起方

Department of Neurology, Tokyo Medical University